Given the critical roles of both AHR and NF-κB signaling pathways in psoriasis, our study demonstrated that IDG acts as a ligand for AHR, activates the AHR signaling pathway, and inhibits the NF-κB signaling pathway. The gene discussed is NFKB1; the disease is psoriasis.